Get started
Author

Giuseppe Caramanno

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
2015 · Davide Capodanno, Tommaso Gori, et al. · EuroIntervention · 457
Coronary Artery Fistulae: Anatomy, Diagnosis and Management Strategies
2018 · Dario Buccheri, Paola Rosa Chirco, et al. · Heart Lung and Circulation · 187
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective
2015 · Corrado Tamburino, Azeem Latib, et al. · EuroIntervention · 154
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
2017 · Luis Ortega-Paz, Davide Capodanno, et al. · EuroIntervention · 137
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
2024 · Kausik K Ray, Carlos Aguiar, et al. · European Journal of Preventive Cardiology · 91
PDF
Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
2019 · Mark Rosenberg, Matthias Waliszewski, et al. · Journal of Interventional Cardiology · 51
PDF
Prospective, large‐scale multicenter trial for the use of drug‐coated balloons in coronary lesions: The DCB‐only All‐Comers Registry
2018 · Mark Rosenberg, Matthias Waliszewski, et al. · Catheterization and Cardiovascular Interventions · 51
Five waves of COVID-19 pandemic in Italy: results of a national survey evaluating the impact on activities related to arrhythmias, pacing, and electrophysiology promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)
2022 · Giuseppe Boriani, Federico Guerra, et al. · Internal and Emergency Medicine · 40
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
2016 · Tommaso Gori, Jens Wiebe, et al. · EuroIntervention · 37
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease
2013 · Flavio Ribichini, Michele Romano, et al. · JACC: Cardiovascular Interventions · 32
PDF
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry
2016 · Toru Naganuma, Antonio Colombo, et al. · Catheterization and Cardiovascular Interventions · 31
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients
2016 · Antonio Colombo, Cosmo Godino, et al. · International Journal of Cardiology · 30
Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper
2022 · L. Golino, G. Caiazzo, et al. · International Journal of Cardiology · 27
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents
2016 · Corrado Tamburino, Piera Capranzano, et al. · JACC: Cardiovascular Interventions · 27
PDF
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
2023 · Giuseppe Tarantini, Luca Nai Fovino, et al. · EuroIntervention · 23
PDF
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions
2017 · Salvatore Geraci, Hiroyoshi Kawamoto, et al. · JACC: Cardiovascular Interventions · 17
Impact of overlapping on 1‐year clinical outcomes in patients undergoing everolimus‐eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST‐EU registry
2016 · Luis Ortega‐Paz, Davide Capodanno, et al. · Catheterization and Cardiovascular Interventions · 16
Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience
2016 · Alfonso Ielasi, Tadashi Miyazaki, et al. · EuroIntervention · 16
Sirolimus-Eluting Magnesium Resorbable Scaffold Implantation in Patients with Acute Myocardial Infarction
2019 · Alfonso Ielasi, Enrico Cerrato, et al. · Cardiology · 14
Impact on hospital admission of ST-elevation myocardial infarction patients during coronavirus disease 2019 pandemic in an Italian Hospital
2020 · Ilenia Alessandra Di Liberto, Gerlando Pilato, et al. · Journal of Cardiovascular Medicine · 13
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry
2023 · Sergio Berti, Alberto Ranieri De Caterina, et al. · Frontiers in Cardiovascular Medicine · 12
PDF
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
2017 · Boris Schnorbus, Jens Wiebe, et al. · EuroIntervention · 11
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry)
2017 · Cosmo Godino, Mauro Chiarito, et al. · International Journal of Cardiology · 11
Intra-Cardiac versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion with a Watchman FLX Device
2023 · Luigi Emilio Pastormerlo, Claudio Tondo, et al. · Journal of Clinical Medicine · 10
PDF
A lesson from intravascular imaging: insights for recognizing a spontaneous coronary artery dissection
2017 · Dario Buccheri, Diego Milazzo, et al. · Journal of Thoracic Disease · 10
PDF
Works count: 56
Citation count: 1,543
H-index: 16
I10-index: 25
Year
Topic
Type